Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nuvo Pharmaceuticals Inc MRVFF

Healthcare Drug Manufacturers - Specialty & Generic
Nuvo Pharmaceuticals Inc is a Canadian focused healthcare company doing business as Miravo Healthcare with global reach and a diversified portfolio of commercial products. Its product targets several therapeutic areas, including pain, allergy, and dermatology. The company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets.


OTCQX:MRVFF - Post by User

Nuvo Pharmaceuticals Inc
Bullboard Posts
User Avatar Image
(1)
•••
Comment by longondmxon Oct 28, 2009 2:02pm
484 Views
Post# 16431890

RE: RE: RE: AS I SEE IT !!!

RE: RE: RE: AS I SEE IT !!!Just to expand on my last post, the words "the Agency determined to be a major amendment to the Pennsaid New Drug Application" is obviously related to the label on Pennsaid...it has to be especially since Covidien's deal and the extra $$$ Nuvo could get from them involves labelling. 

So, again, with approval, and definitely with a better label, how can you not agree a 3-4-fold jump in the price of the stock is not warranted.  That still takes us to a $700 million market value which is not far fetched in my mind...but I guess time will tell.
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities